Full-length genomic analysis of hepatitis B virus isolates in a patient progressing from hepatitis to hepatocellular carcinoma.
In hepatitis B virus (HBV)-endemic countries, the majority of hepatocellular carcinoma (HCC) arises in HBV carriers. High frequency of mutations at nucleotides 1762(A-->T) and 1764(G-->A) in the core promoter region have been described in HCC. Due to the differences in genetic backgrounds, environmental risk factors and random cellular insertion sites, it is difficult to analyze the possible roles of HBV variants detected in different HCC patients. In a follow-up cohort study, an HBsAg-positive asymptomatic carrier was diagnosed HCC within 4 years. Eleven full-length HBV isolates, three from the first serum sample obtained 4 years pre-HCC, and eight from serum sample, peri-tumor and tumor tissue post-HCC of this individual were sequenced and used to transfect HepG2 cells. When sequences were compared between pre- and post-HCC isolates, no single mutation common to all post-HCC isolates that differed from pre-HCC isolates was found. Among all 11 isolates, there were 20 predicted amino acid substitutions shared by two or more post-HCC isolates. These were located in the S(5), X(4), core(4), polymerase(4), pre-S1(2) and pre-S2(1) proteins. Possible roles of amino acid substitutions and enhanced replication efficiency in cells transfected by post-HCC isolates are discussed.
Lin
X
X
Department of Molecular Virology, Shanghai Medical University, Shanghai, China.
Qian
G S
GS
Lu
P X
PX
Wu
L
L
Wen
Y M
YM
D019943:Amino Acid Substitution; D006528:Carcinoma, Hepatocellular / Q000150:complications* / Q000235:genetics / Q000276:immunology; D002353:Carrier State / Q000097:blood / Q000821:virology*; D002874:Chromosome Mapping; D015331:Cohort Studies; D004279:DNA, Viral / Q000235:genetics*; D012321:DNA-Directed RNA Polymerases; D018450:Disease Progression; D005500:Follow-Up Studies; D014644:Genetic Variation; D006509:Hepatitis B / Q000276:immunology / Q000821:virology*; D006510:Hepatitis B Antibodies / Q000032:analysis / Q000276:immunology; D006512:Hepatitis B Core Antigens / Q000032:analysis / Q000235:genetics / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000032:analysis / Q000235:genetics / Q000276:immunology; D006515:Hepatitis B virus / Q000235:genetics* / Q000276:immunology / Q000302:isolation & purification; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications* / Q000235:genetics / Q000276:immunology; D016133:Polymerase Chain Reaction; D011401:Promoter Regions, Genetic; D013997:Time Factors; D014162:Transfection; D014764:Viral Proteins / Q000032:analysis / Q000235:genetics*
D004279:DNA, Viral; D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D014764:Viral Proteins; D012321:DNA-Directed RNA Polymerases